154 related articles for article (PubMed ID: 38694344)
1. Macrophage activation syndrome in a Sudanese child: a case report from Sudan.
Yahia Elhassan MA; Hussain Idres RM; Mohamed Elhassan BMS; Banaga Siddiq NS; Osman Mohammed RA; Mahmmoud Fadelallah Eljack M; Mustafa GE; Hemmeda L; Abbasher Hussien Mohamed Ahmed K
Ann Med Surg (Lond); 2024 May; 86(5):3047-3051. PubMed ID: 38694344
[TBL] [Abstract][Full Text] [Related]
2. Prolonged Fever in a Pediatric Patient: A Case of Systemic Juvenile Idiopathic Arthritis (sJIA) Complicated by Macrophage Activation Syndrome (MAS).
Cortes M; Nudelman BG; Rouse MJ; Frost MD
Cureus; 2023 Sep; 15(9):e46083. PubMed ID: 37900539
[TBL] [Abstract][Full Text] [Related]
3. Macrophage Activation Syndrome (MAS): A Case Report and Narrative Review.
Dilibe A; Ugoala OS; Evbayekha EO; Khalilullah MZ; Adabale OK; Poyser TA; Oriaifo OF; Olori UI; Aiwuyo HO
Cureus; 2023 Mar; 15(3):e35670. PubMed ID: 37012949
[TBL] [Abstract][Full Text] [Related]
4. Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Chellapandian D; Milojevic D
Front Pediatr; 2023; 11():1123104. PubMed ID: 36891226
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
6. Anakinra and hepatotoxicity in pediatric rheumatology: a case series.
Martins FR; Azevedo AC; Ganhão S; Aguiar F; Rodrigues M; Brito I
Pediatr Rheumatol Online J; 2023 Oct; 21(1):112. PubMed ID: 37803456
[TBL] [Abstract][Full Text] [Related]
7. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
Batu ED; Sener S; Balık Z; Bayındır Y; Cam V; Kasap Cuceoglu M; Uysal O; Aliyev E; Basaran Ö; Bilginer Y; Özen S
Clin Rheumatol; 2024 Jan; 43(1):415-421. PubMed ID: 38012469
[TBL] [Abstract][Full Text] [Related]
8. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
[TBL] [Abstract][Full Text] [Related]
9. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
[TBL] [Abstract][Full Text] [Related]
10. Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Gorelik M; Fall N; Altaye M; Barnes MG; Thompson SD; Grom AA; Hirsch R
J Rheumatol; 2013 Jul; 40(7):1191-9. PubMed ID: 23678162
[TBL] [Abstract][Full Text] [Related]
11. Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.
Macaraeg M; Schulert GS
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36690384
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis.
Jain D; Aggarwal HK; Rao A; Mittal A; Jain P
Reumatologia; 2016; 54(1):42-7. PubMed ID: 27407277
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation syndrome in juvenile idiopathic arthritis.
Cortis E; Insalaco A
Acta Paediatr Suppl; 2006 Jul; 95(452):38-41. PubMed ID: 16801165
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic plasma exchange in refractory macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a case-based review.
Liquidano-Perez E; Maza-Ramos G; Salazar-Bailón JL; Yamazaki-Nakashimada MA; Rivas-Larrauri F
Rheumatol Int; 2023 Jan; 43(1):183-189. PubMed ID: 36264324
[TBL] [Abstract][Full Text] [Related]
15. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
[TBL] [Abstract][Full Text] [Related]
16. Unusual acute lupus hemophagocytic syndrome - a test of diagnostic criteria: a case report.
Wijetunga WMUA; Satarasinghe RL; Dayananda BM; Darshani GK
J Med Case Rep; 2017 Jul; 11(1):185. PubMed ID: 28683778
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA
Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Inoue N; Schulert GS
Arthritis Res Ther; 2023 Mar; 25(1):48. PubMed ID: 36964620
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
20. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
